Grape King Bio Ltd (TPE:1707)

Grape King Bio Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,343	4,819	4,673	3,635	2,927
Short-Term Investments	48.81	71.15	117.05	61.86	77.66
Trading Asset Securities	40.6	80.06	-	200.38	-
Cash & Short-Term Investments	4,432	4,970	4,790	3,897	3,005
Cash Growth	-10.82%	3.76%	22.90%	29.71%	34.62%
Accounts Receivable	304.82	290.81	269.65	300.7	201.7
Other Receivables	30.71	24.58	14.36	13.13	3.55
Receivables	335.53	315.39	284.01	313.82	205.24
Inventory	813.64	737.19	707.51	743.47	721.05
Prepaid Expenses	13.8	15.09	16.23	28.38	34.27
Other Current Assets	1.19	1.2	3.61	2.2	6.17
Total Current Assets	5,596	6,039	5,801	4,985	3,971
Property, Plant & Equipment	7,886	7,756	7,546	7,417	7,510
Long-Term Investments	86.69	60.06	59	36.74	16.45
Other Intangible Assets	118.72	125.09	43.76	33.34	38.34
Long-Term Deferred Tax Assets	10.36	11.63	14.66	8.71	10.87
Other Long-Term Assets	1,626	1,520	1,588	1,579	1,557
Total Assets	15,324	15,512	15,053	14,061	13,104
Accounts Payable	309.44	290.1	293.84	335.77	255.32
Accrued Expenses	1,736	1,739	2,003	1,760	1,770
Short-Term Debt	-	-	-	-	500
Current Portion of Long-Term Debt	-	-	-	6.99	49.11
Current Portion of Leases	53.95	56.56	46.94	48.31	41.8
Current Income Taxes Payable	340.42	1,069	1,026	925.72	723.26
Current Unearned Revenue	143.47	151.13	174.59	135.17	102.25
Other Current Liabilities	739.99	341.65	168.32	81.88	58.91
Total Current Liabilities	3,323	3,647	3,712	3,294	3,501
Long-Term Debt	-	-	-	87.38	1,372
Long-Term Leases	106.96	136.36	110.81	129.08	120.93
Long-Term Deferred Tax Liabilities	82.73	77.65	69.7	69	68.8
Other Long-Term Liabilities	20.21	20.3	18.75	50.12	61.63
Total Liabilities	3,533	3,882	3,912	3,631	5,126
Common Stock	1,481	1,481	1,481	1,481	1,363
Additional Paid-In Capital	2,879	2,876	2,874	2,870	971.72
Retained Earnings	5,730	5,700	5,285	4,729	4,376
Comprehensive Income & Other	-34.76	-79.56	-70.83	-92.21	-86.47
Total Common Equity	10,056	9,978	9,570	8,988	6,624
Minority Interest	1,735	1,652	1,571	1,441	1,354
Shareholders' Equity	11,791	11,630	11,141	10,429	7,978
Total Liabilities & Equity	15,324	15,512	15,053	14,061	13,104
Total Debt	160.91	192.92	157.75	271.76	2,084
Net Cash (Debt)	4,271	4,777	4,632	3,626	920.7
Net Cash Growth	-10.59%	3.13%	27.76%	293.79%	3.47%
Net Cash Per Share	28.63	32.03	31.08	24.43	6.73
Filing Date Shares Outstanding	148.14	148.14	148.14	148.14	136.29
Total Common Shares Outstanding	148.14	148.14	148.14	148.14	136.29
Working Capital	2,273	2,391	2,089	1,691	470.85
Book Value Per Share	67.88	67.36	64.60	60.68	48.61
Tangible Book Value	9,937	9,853	9,526	8,955	6,586
Tangible Book Value Per Share	67.08	66.51	64.31	60.45	48.33
Land	2,965	2,965	2,965	2,965	2,965
Buildings	5,316	4,923	4,439	4,413	4,321
Machinery	2,823	2,431	2,432	2,340	2,203
Construction In Progress	162.14	386.26	448.18	104.07	107.73
Leasehold Improvements	108.51	108.43	108.01	85.8	85.53

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.